Literature DB >> 19542740

Degree of catecholamine hypersecretion is the most important determinant of intra-operative hemodynamic outcomes in pheochromocytoma.

C K Kramer1, C B Leitão, M J Azevedo, L H Canani, A L Maia, M Czepielewski, A Paggi, T C Rodrigues, S P Silveiro, R Friedman, J L Gross.   

Abstract

Pheochromocytoma resection is often complicated by intra-operative hypertension and post-resection hypotension. Factors associated with these hemodynamic alterations are not well defined. The aim of this study was to analyse the clinical-laboratory features associated with hemodynamic parameters during pheochromocytoma resection. Twenty-seven patients submitted to tumor resection - either open (no.=18) or video laparoscopic - between 1978-2007 were included. Nineteen received pre-operative alpha-blockers. Intra-operative hemodynamic data analysed were: maximum and minimum mean arterial blood pressure (MABP), no. of severe hypertensive (systolic BP >200 mmHg) and hypotensive episodes (MABP <60 mmHg), maximum and minimum heart rate (HR), no. of episodes of tachycardia and bradycardia, need to receive iv intra-operative treatment for hypertension and hypotension and the volume of fluids administered during surgery. Patients were 39.4+/-14.4-yr-old, 66% women. Intra-operative hemodynamic parameters were not different in patients submitted to open or video laparoscopic resection. Maximum intraoperative HR and the percentage of patients with HR>100 beats/min were higher in patients without pre-operative alpha- blocker treatment (no.=8). Pre-operative urinary vanylmandelic acid was positively associated with intra-operative maximum MABP (r=0.535, p=0.047) and with maximum transoperative systolic BP (r=0.805, p=0.016). Pre-operative urinary catecholamine (Pearson correlation r=0.575, p=0.03) and vanylmandelic acid (Pearson correlation r=0.605, p=0.04) levels were associated with maximum intra- operative MABP, adjusted for the presence of pheochromocytoma symptoms, surgical approach and pre-operative alpha-blockers. In conclusion, the degree of pre-operative catecholamine secretion was the most important aspect of transoperative BP control.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542740     DOI: 10.1007/BF03346458

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

2.  Plasma catecholamine changes during excision of pheochromocytoma.

Authors:  K A Newell; R A Prinz; M H Brooks; S N Glisson; A L Barbato; R J Freeark
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

Review 3.  Preoperative pharmacological management of phaeochromocytoma.

Authors:  A N A van der Horst-Schrivers; M N Kerstens; B H R Wolffenbuttel
Journal:  Neth J Med       Date:  2006-09       Impact factor: 1.422

4.  Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center.

Authors:  P F Plouin; J M Duclos; F Soppelsa; G Boublil; G Chatellier
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

5.  Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine.

Authors:  G A Smythe; G Edwards; P Graham; L Lazarus
Journal:  Clin Chem       Date:  1992-04       Impact factor: 8.327

6.  Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection.

Authors:  M A Kinney; M E Warner; J A vanHeerden; T T Horlocker; W F Young; D R Schroeder; P M Maxson; M A Warner
Journal:  Anesth Analg       Date:  2000-11       Impact factor: 5.108

Review 7.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

8.  Anesthetic aspects of laparoscopic and open adrenalectomy for pheochromocytoma.

Authors:  J Sprung; J F O'Hara; I S Gill; B Abdelmalak; A Sarnaik; E L Bravo
Journal:  Urology       Date:  2000-03       Impact factor: 2.649

9.  Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.

Authors:  E L Bravo; R C Tarazi; R W Gifford; B H Stewart
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

10.  RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome.

Authors:  Marcia K Puñales; Hans Graf; Jorge L Gross; Ana Luiza Maia
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

View more
  3 in total

1.  Epidural anesthesia and hypotension in pheochromocytoma and paraganglioma.

Authors:  Douglas Wiseman; James D McDonald; Dhaval Patel; Electron Kebebew; Karel Pacak; Naris Nilubol
Journal:  Endocr Relat Cancer       Date:  2020-09       Impact factor: 5.678

2.  Pheochromocytoma crisis with severe cyclic blood pressure fluctuations in a cardiac pheochromocytoma patient successfully resuscitated by extracorporeal membrane oxygenation: a case report.

Authors:  Xiang Zhou; Dawei Liu; Longxiang Su; Yun Long; Wei Du; Qi Miao; Fang Li; Zhengyu Jin; Zhengpei Zeng; Ailun Luo; Yuguang Huang
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

3.  Newer therapies in the operative management of phaeochromocytoma.

Authors:  Sukhminder Jit Singh Bajwa
Journal:  Indian J Endocrinol Metab       Date:  2013-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.